Henrietta Lacks' Cells Contributed to Breakthrough Medical Advancements. Now, Her Family Will Finally be Compensated.
The news comes after two years of litigation in federal court—on what would have been Lacks’ 103rd birthday.
Jessica Calefati The Baltimore Banner
The latest issue of In These Times is a special, extra-length issue devoted entirely to the subject of socialism in America today. This special issue is available now. Order your copy today.
This story was originally published by The Baltimore Banner.
Henrietta Lacks’ living relatives gathered Tuesday morning in a sunny Baltimore waterfront park to herald the settlement they reached with a multibillion-dollar biotechnology company that for years has profited off its free use of regenerative cells taken from her decades ago without her consent.
News of the agreement between the Lacks family and Massachusetts-based Thermo Fisher Scientific came after two years of litigation in federal court on what would have been the Turner Station wife and mother’s 103rd birthday.
Several family members attributed the serendipitous timing of the development to divine intervention.
“I can think of no better present,” said famed civil rights attorney Ben Crump, who represents Lacks’ relatives, “than to give her family some measure of respect for Henrietta Lacks, some measure of dignity for Henrietta Lacks, and most of all, some measure of justice for Henrietta Lacks.”
Lacks’ relatives celebrated with Turkey Hill iced tea, balloons, cupcakes and a cake topped with candles they couldn’t manage to light in the waterfront breeze.
Although both sides agreed to keep the settlement terms confidential, Crump and Chris Ayers, another member of the family’s legal team, stressed Tuesday that this case will be the first in a series of complaints they plan to file seeking compensation for, and control of, Lacks’ “HeLa cells,” which were the first in the world capable of replicating outside the body.
HeLa cells have since been used to develop the polio and Covid-19 vaccines and the world’s most common fertility treatment.
“These companies profit today,” said Ayers, a partner in the New Jersey-based Seeger Weiss law firm. “If they can profit today, they can provide compensation today.”
The Lacks lawsuit raised a question that had lingered since her cells were taken while she received cervical cancer treatment in a segregated Johns Hopkins Hospital ward more than 70 years ago: Who owns those tiny pieces of her?
Her descendants insist her cells belong to her, because they are part of her, and companies like Thermo Fisher must pay for the privilege to use them in research and product development. Company officials previously said they shouldn’t be singled out for using HeLa cells without the family’s consent because countless others around the world do the same thing.
“The parties are pleased that they were able to find a way to resolve this matter outside of court and will have no further comment,” the company said in a statement.
Lacks’ 1951 cancer treatment did not work, and she succumbed to the disease within a few months of her diagnosis.
Around the time of her death, Hopkins researchers discovered the cells they had secretly sampled from their patient’s cervix were capable of regenerating outside the body, and they shared Lacks’ miraculous cells with other scientists for free. They’re now widely used around the world.
Absent from Tuesday’s news conference was Lawrence Lacks, 86, Henrietta Lacks’ only living son, whose health is failing. Lawrence’s son Ron Lacks said his father asked him recently to take the case “to the finish line.” Knowing he had brought a mix of joy and satisfaction, he added.
“It couldn’t have been a more fitting day for her family to have justice, and for her family to have relief,” said Alfred Lacks-Carter, another grandson of Henrietta Lacks.
For many years, Lacks’ contributions to science went unrecognized, but U.S. Rep. Kweisi Mfume, who represents sections of Baltimore City and Baltimore County, and U.S. Sens. Chris Van Hollen and Ben Cardin are seeking to change that. They’ve introduced legislation that would posthumously grant Lacks a Congressional Gold Medal.
Crump said he hopes the settlement and the possible recognition from Congress cement Lacks’ place in history alongside men like President John F. Kennedy and Henry Ford.
“Black women have done so much to help build America. To help build the world,” Crump said. “But everybody in America doesn’t know who Henrietta Lacks is, and that is an injustice. And that’s why we’re fighting. Because Black history is American history. Henrietta Lacks is American history.”
Celebrate 47 years of In These Times in style! Get your raffle tickets today for your chance to win a vacation for two to Cascais, Portugal!
One lucky raffle winner will receive a $3,000 gift card to cover the costs of two flights, as well as a stay in a 5-star boutique hotel, housed in a 17th century fortress with medieval architecture and décor. You can schedule the trip on your timeline!
All raffle ticket sales support ongoing In These Times reporting, just like the article you just finished reading. Get your raffle tickets now.
The winner will be selected on the night of September 30, at the In These Times 47th Anniversary Celebration. You do not need to be present at the drawing to win.
Jessica Calefati is an education enterprise reporter exploring how Johns Hopkins University is shaping Baltimore’s future. Her work has been recognized by the Gerald Loeb Awards, the National Headliner Awards, the Keystone Media Awards, the Society of Professional Journalists NorCal, the New Jersey Press Association and others.